Jean-Francois Sarrazin

Dr. Jean-Francois Sarrazin

orcid

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 July 2016 in New England Journal of Medicine
Verified
Journal Article
Closed access
PDF file
JSJohn L. Sapp
John L. Sapp
GWGeorge A. Wells
George A. Wells
RPRatika Parkash
Ratika Parkash
WSWilliam G. Stevenson
William G. Stevenson
LBLouis Blier
Louis Blier
ATAnthony S.L. Tang
Anthony S.L. Tang
Recurrent ventricular tachycardia among survivors of myocardial infarction with an implantable cardioverter–defibrillator (ICD) is frequent despite antiarrhythmic drug therapy. The most effective approach to management of this problem is uncertain.

22 May 2007 in Circulation
Verified
Journal Article
Closed access
PDF file
HOHakan Oral
Hakan Oral
ACAman Chugh
Aman Chugh
EGEric Good
Eric Good
AWAlan Wimmer
Alan Wimmer
SDSujoya Dey
Sujoya Dey
FMFred Morady
Fred Morady
Background— Radiofrequency catheter ablation of atrial fibrillation (AF) guided by complex fractionated atrial electrograms has been reported to eliminate AF in a large proportion of patients. However, only a small number of patients with chronic AF have been included in previous studies. Methods and Results— In 100 patients (mean age, 57±11 years) with chronic AF, radiofrequency ablation was performed to target complex fractionated atrial electrograms at the pulmonary vein ostial and antral areas, various regions of the left atrium, and the coronary sinus until AF terminated or all identified complex fractionated atrial electrograms were eliminated. Ablation sites consisted of ≥1 pulmonary vein in 46% of patients; the left atrial septum, roof, or anterior wall in all; and the coronary sinus in 55%. During 14±7 months of follow-up after a single ablation procedure, 33% of patients were in sinus rhythm without antiarrhythmic drugs, 38% had AF, 17% had both AF and atrial flutter, 9% had persistent atrial flutter, and 3% had paroxysmal AF on antiarrhythmic drugs. A second ablation procedure was performed in 44% of patients. Pulmonary vein tachycardia was found in all patients in both previously targeted and nontargeted pulmonary veins. There were multiple macroreentrant circuits in the majority of patients with atrial flutter. At 13±7 months after the last ablation procedure, 57% of patients were in sinus rhythm without antiarrhythmic drugs, 32% had persistent AF, 6% had paroxysmal AF, and 5% had atrial flutter. Conclusions— Modest short-term efficacy is achievable with radiofrequency ablation of chronic AF guided by complex fractionated atrial electrograms, but only after a second ablation procedure in >40% of patients. Rapid activity in the pulmonary veins and multiple macroreentrant circuits are common mechanisms of recurrent atrial arrhythmias.

1 October 2007 in JACC
Verified
Journal Article
Closed access
SCSanders Chae
Sanders Chae
HOHakan Oral
Hakan Oral
EGEric Good
Eric Good
SDSujoya Dey
Sujoya Dey
AWAlan Wimmer
Alan Wimmer
ACAman Chugh
Aman Chugh

1 June 2015 in JACC: Clinical Electrophysiology
Verified
Journal Article
Closed access
RLRakesh Latchamsetty
Rakesh Latchamsetty
MYMiki Yokokawa
Miki Yokokawa
FMFred Morady
Fred Morady
HKHyungjin Myra Kim
Hyungjin Myra Kim
SMShibu Mathew
Shibu Mathew
FBFrank Bogun
Frank Bogun

1 March 2009 in JACC
Verified
Journal Article
Closed access
HOHakan Oral
Hakan Oral
ACAman Chugh
Aman Chugh
KYKentaro Yoshida
Kentaro Yoshida
JSJean-Francois Sarrazin
Jean-Francois Sarrazin
MKMichael Kuhne
Michael Kuhne
FMFred Morady
Fred Morady

1 May 2012 in JACC
Verified
Journal Article
Closed access
JSJean-Francois Sarrazin
Jean-Francois Sarrazin
FPFrançois Philippon
François Philippon
MTMichel Tessier
Michel Tessier
JGJean Guimond
Jean Guimond
FMFranck Molin
Franck Molin
GOGilles O'HAra
Gilles O'HAra